Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Equities researchers at Ventum Cap Mkts issued their Q1 2025 earnings per share estimates for shares of Green Thumb Industries in a note issued to investors on Thursday, February 27th. Ventum Cap Mkts analyst A. Semple expects that the company will post earnings of $0.06 per share for the quarter. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share. Ventum Cap Mkts also issued estimates for Green Thumb Industries' Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.08 EPS, Q4 2025 earnings at $0.08 EPS and FY2026 earnings at $0.30 EPS.
Separately, Roth Capital upgraded Green Thumb Industries to a "strong-buy" rating in a report on Sunday, November 10th. Two equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Strong Buy" and a consensus target price of $16.50.
View Our Latest Stock Analysis on GTBIF
Green Thumb Industries Stock Performance
Green Thumb Industries stock traded up $0.08 during trading on Friday, reaching $7.03. The company had a trading volume of 1,226,877 shares, compared to its average volume of 487,654. The firm's 50-day simple moving average is $7.33 and its 200 day simple moving average is $8.91. The firm has a market capitalization of $1.49 billion, a PE ratio of 29.29 and a beta of 1.31. Green Thumb Industries has a 1-year low of $6.60 and a 1-year high of $16.33.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%. The firm had revenue of $294.32 million for the quarter, compared to analyst estimates of $289.66 million.
Green Thumb Industries Company Profile
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
See Also
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
